Millennium Management’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-7,700
| Closed | -$228K | – | 6856 |
|
|
2023
Q4 | $228K | Buy |
+7,700
| New | +$153K | ﹤0.01% | 5112 |
|
|
2023
Q3 | – | Sell |
-50,000
| Closed | -$944K | – | 6728 |
|
|
2023
Q2 | $944K | Sell |
50,000
-200,000
| -80% | -$2.36M | ﹤0.01% | 4091 |
|
|
2023
Q1 | $960K | Buy |
+250,000
| New | +$1.07M | ﹤0.01% | 4131 |
|
|
2022
Q4 | – | Sell |
-57,200
| Closed | -$273K | – | 7250 |
|
|
2022
Q3 | $273K | Buy |
+57,200
| New | +$302K | ﹤0.01% | 5450 |
|
|
2022
Q1 | – | Sell |
-100,000
| Closed | -$742K | – | 7727 |
|
|
2021
Q4 | $742K | Buy |
+100,000
| New | +$621K | ﹤0.01% | 4696 |
|
|
2021
Q2 | – | Sell |
-100,000
| Closed | -$810K | – | 7289 |
|
|
2021
Q1 | $810K | Buy |
+100,000
| New | +$817K | ﹤0.01% | 4411 |
|
|
2019
Q2 | – | Sell |
-500,000
| Closed | -$1.35M | – | 4585 |
|
|
2019
Q1 | $1.35M | Buy |
500,000
+100,000
| +25% | +$433K | ﹤0.01% | 2677 |
|
|
2018
Q4 | $1.92M | Buy |
+400,000
| New | +$2.43M | ﹤0.01% | 2205 |
|
|
2018
Q3 | – | Sell |
-35,000
| Closed | -$341K | – | 4370 |
|
|
2018
Q2 | $341K | Sell |
35,000
-31,400
| -47% | -$331K | ﹤0.01% | 3331 |
|
|
2018
Q1 | $699K | Buy |
+66,400
| New | +$656K | ﹤0.01% | 2876 |
|
|
2015
Q1 | – | Sell |
-300,000
| Closed | -$1.83M | – | 4226 |
|
|
2014
Q4 | $1.83M | Buy |
+300,000
| New | +$2.74M | ﹤0.01% | 2040 |
|
Other funds holding IMGN
Millennium Management's IMGN Position: Q1 2024 in Review
Millennium Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 4,473,868 shares — an estimated $133M sold.
Millennium Management first reported a position in IMGN in Q3 2013 and held it in 41 quarters. The position peaked at $133M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Millennium Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Millennium Management sold 4,473,868 Immunogen Inc shares in Q1 2024, an estimated $133M.
- Millennium Management first reported a position in Immunogen Inc in Q3 2013 and held it in 41 quarters.
- Millennium Management's Immunogen Inc position peaked at $133M in Q4 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.